SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001566044-21-000010
Filing Date
2021-03-04
Accepted
2021-03-04 07:17:51
Documents
103
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vyne-20201231.htm   iXBRL 10-K 2499795
2 EX-3.1 exhibit31vynecertificateof.htm EX-3.1 84388
3 EX-4.1 exhibit41.htm EX-4.1 25304
4 EX-10.11C a1011c-formofrsuagreement2.htm EX-10.11C 55553
5 EX-21.1 exhibit211listofsubsidiari.htm EX-21.1 3481
6 EX-23.1 exhibit231consentus.htm EX-23.1 2223
7 EX-23.2 exhibit232consentisr.htm EX-23.2 4677
8 EX-31.1 vyne-20201231xexx311.htm EX-31.1 10836
9 EX-31.2 vyne-20201231xexx312.htm EX-31.2 10824
10 EX-32.1 vyne-20201231xexx321.htm EX-32.1 6979
11 EX-32.2 vyne-20201231xexx322.htm EX-32.2 6940
17 vyne-20201231_g1.jpg GRAPHIC 281743
18 vyne-20201231_g2.jpg GRAPHIC 67818
19 vyne-20201231_g3.jpg GRAPHIC 62269
  Complete submission text file 0001566044-21-000010.txt   11419935

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vyne-20201231.xsd EX-101.SCH 64034
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vyne-20201231_cal.xml EX-101.CAL 116191
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vyne-20201231_def.xml EX-101.DEF 381699
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vyne-20201231_lab.xml EX-101.LAB 849303
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vyne-20201231_pre.xml EX-101.PRE 596901
20 EXTRACTED XBRL INSTANCE DOCUMENT vyne-20201231_htm.xml XML 1554109
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38356 | Film No.: 21712563
SIC: 2834 Pharmaceutical Preparations